Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Peroxisomal β-oxidation regulates whole body metabolism, inflammatory vigor, and pathogenesis of nonalcoholic fatty liver disease
Maria E. Moreno-Fernandez, Daniel A. Giles, Traci E. Stankiewicz, Rachel Sheridan, Rebekah Karns, Monica Cappelletti, Kristin Lampe, Rajib Mukherjee, Christian Sina, Anthony Sallese, James P. Bridges, Simon P. Hogan, Bruce J. Aronow, Kasper Hoebe, Senad Divanovic
Maria E. Moreno-Fernandez, Daniel A. Giles, Traci E. Stankiewicz, Rachel Sheridan, Rebekah Karns, Monica Cappelletti, Kristin Lampe, Rajib Mukherjee, Christian Sina, Anthony Sallese, James P. Bridges, Simon P. Hogan, Bruce J. Aronow, Kasper Hoebe, Senad Divanovic
View: Text | PDF
Research Article Inflammation Metabolism

Peroxisomal β-oxidation regulates whole body metabolism, inflammatory vigor, and pathogenesis of nonalcoholic fatty liver disease

  • Text
  • PDF
Abstract

Nonalcoholic fatty liver disease (NAFLD), a metabolic predisposition for development of hepatocellular carcinoma (HCC), represents a disease spectrum ranging from steatosis to steatohepatitis to cirrhosis. Acox1, a rate-limiting enzyme in peroxisomal fatty acid β-oxidation, regulates metabolism, spontaneous hepatic steatosis, and hepatocellular damage over time. However, it is unknown whether Acox1 modulates inflammation relevant to NAFLD pathogenesis or if Acox1-associated metabolic and inflammatory derangements uncover and accelerate potential for NAFLD progression. Here, we show that mice with a point mutation in Acox1 (Acox1Lampe1) exhibited altered cellular metabolism, modified T cell polarization, and exacerbated immune cell inflammatory potential. Further, in context of a brief obesogenic diet stress, NAFLD progression associated with Acox1 mutation resulted in significantly accelerated and exacerbated hepatocellular damage via induction of profound histological changes in hepatocytes, hepatic inflammation, and robust upregulation of gene expression associated with HCC development. Collectively, these data demonstrate that β-oxidation links metabolism and immune responsiveness and that a better understanding of peroxisomal β-oxidation may allow for discovery of mechanisms central for NAFLD progression.

Authors

Maria E. Moreno-Fernandez, Daniel A. Giles, Traci E. Stankiewicz, Rachel Sheridan, Rebekah Karns, Monica Cappelletti, Kristin Lampe, Rajib Mukherjee, Christian Sina, Anthony Sallese, James P. Bridges, Simon P. Hogan, Bruce J. Aronow, Kasper Hoebe, Senad Divanovic

×

Figure 5

Acox1Lampe1 mutation in hematopoietic cells contributes to exacerbated hepatocellular damage and systemic inflammation during short-term obesogenic-diet challenge.

Options: View larger image (or click on image) Download as PowerPoint
Acox1Lampe1 mutation in hematopoietic cells contributes to exacerbated h...
Eight- ton 10-week-old WT mice were lethally irradiated and subsequently reconstituted with BM from WT or Acox1Lampe1 mice. Following successful immunological reconstitution, mice were fed a HFHCD for 4 weeks. (A) Schematic representation. (B) Weight gain. (C) Hepatic TG levels. (D) Representative liver histology (H&E staining; 20×). (E) Serum ALT levels. (F) Total hepatic immune (CD45+) cell infiltration determined by flow cytometry. (G) Hepatic chemokine mRNA expression of Ccl2, Ccl3, Ccl4, Ccl22, and Cxcl10. (H) Frequency of hepatic CD45+TCRB+CD4+ T cells producing IFN-γ, TNF-α, and IL-17A. (I) Frequency of hepatic CD45+TCRB+CD8+ T cells producing IFN-γ and TNF-α. (J) Mice were challenged i.p. with biotinylated capture Ab (20 μg/mouse) for 3 hours, and serum IL-6, TNF-α, IFN-γ, and IL-17A levels were quantified by IVCCA ELISA. Data represent means ± SEM. (B–J) Unpaired Student’s t test; *P < 0.05, **P < 0.01. A single experiment, n = 5–6/condition.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts